NIGM is a form of non-invasive prenatal testing (NIPT) based on next generation sequencing using cell-free DNA (cfDNA) in maternal blood to evaluate possible chromosomal conditions in a pregnancy and can be performed as early as 9 gestational weeks using a single tube of blood. NIGM offers the prenatal test, with a focused and clinically relevant menu that screens for chromosomal aneuploidies, specific sex chromosome aneuploidies, and pathogenic microdeletions/duplications.
Simple
Test from a small 10ml maternal blood sample as early as 9 gestational weeks
Accurate Proven >99% sensitivity based on a test of more than 20,000 pregnancies.
Fast & Convenient - Quick test from sample preparation to report generation within 24 hours
- Simplified operation: Automated and localized data analysis and report
Flexible Compatible with most standard NGS library prep kits and bioinformatics tools
Compared with the traditional embryo morphology that relies on picking embryos with a microscope, preimplantation genetic screening (PGT) based on DNA sequencing can directly detect the genetic material of embryos. Cell separation and sequencing in the blastomere developed to the 3rd day of the fertilized egg or the blastocyst stage trophoblast developed to the 5th day, and the abnormal structure and number of 23 pairs of chromosomes were analyzed at one time. It provides reliable genetic information reference for choosing healthy embryo transfer, increases the effective pregnancy rate of IVF, and reduces the abortion rate.
Simple
Test from a small 10ml maternal blood sample as early as 9 gestational weeks
Accurate
Proven >99% sensitivity based on a test of more than 20,000 pregnancies.
Fast & Convenient
- Quick test from sample preparation to report generation within 24 hours
- Simplified operation: Automated and localized data analysis and report
Flexible
Compatible with most standard NGS library prep kits and bioinformatics tools
Tumor molecular diagnosis based on DNA sequencing can perform genotyping, tumor cell mutation analysis, drug-related targets prediction, and individual genetic differences on patients. It can obtain the most accurate diagnosis results to make personalized treatment plans and choose appropriate therapeutic drugs, so the survival time of patients can be prolonged and quality of life will be improved. In addition, for Individuals with a family history of cancer, genetic testing of cancer can help them assess the risk of cancer, and early detection and prevention.
Simple
Test from a small 10ml maternal blood sample as early as 9 gestational weeks
Accurate
Proven >99% sensitivity based on a test of more than 20,000 pregnancies.
Fast & Convenient
- Quick test from sample preparation to report generation within 24 hours
- Simplified operation: Automated and localized data analysis and report
Flexible
Compatible with most standard NGS library prep kits and bioinformatics tools
